International Protection from PRC Fentanyl and Other Synthetic Opioids Act
Latest Action
Referred to the Committee on Ways and Means, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The International Protection from PRC Fentanyl and Other Synthetic Opioids Act is a House bill introduced in the 118th Congress aimed at addressing issues related to fentanyl and synthetic opioids originating from the People's Republic of China (PRC). The bill was referred to the Committee on Ways and Means and the Committee on the Judiciary for consideration. The bill's text and detailed summary are not available, but it falls under the policy area of Crime and Law Enforcement and appears to focus on international aspects of controlling synthetic opioid trafficking or related enforcement measures.
This bill seeks to enhance U.S. efforts to combat fentanyl and synthetic opioid threats linked to the PRC, but it did not advance beyond committee referral and has expired.
- The bill targets fentanyl and other synthetic opioids associated with the PRC.
- It was referred to two key House committees: Ways and Means, and Judiciary.
- The bill did not progress to enactment and is currently classified as failed or expired.
['Federal law enforcement agencies involved in drug interdiction and enforcement', 'Public health and safety sectors concerned with opioid abuse', 'Communities affected by synthetic opioid distribution']
['Lack of available full bill text limits understanding of specific provisions and enforcement mechanisms', 'Potential challenges in international cooperation or enforcement against foreign entities', 'Unclear funding sources or budgetary impacts due to missing detailed legislative text']
The bill was introduced during the 118th Congress and referred to committees with jurisdiction over taxation, trade, and legal enforcement matters. It addresses ongoing concerns about synthetic opioid trafficking linked to China, a subject of bipartisan interest. However, the bill did not advance past committee referral and expired without further legislative action.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Potential increased scrutiny or regulatory measures on imports from the PRC related to synthetic opioids', 'Possible shifts in international trade or diplomatic relations due to enforcement actions', 'Enhanced resource allocation to federal agencies for drug interdiction efforts']
The lack of publicly available full bill text and official summary limits comprehensive analysis and transparency. Tracking the bill's referral to multiple committees indicates jurisdictional complexity. The bill's expiration status suggests it did not receive sufficient legislative support or prioritization. Future transparency would benefit from timely publication of bill texts and summaries to enable informed public and stakeholder review.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.